{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T16:49:16Z","timestamp":1767372556077},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T00:00:00Z","timestamp":1360195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T00:00:00Z","timestamp":1360195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1038\/gt.2013.6","type":"journal-article","created":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T11:54:15Z","timestamp":1360238055000},"page":"868-873","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lack of genotoxicity due to foamy virus vector integration in human iPSCs"],"prefix":"10.1038","volume":"20","author":[{"given":"D R","family":"Deyle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I F","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D W","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,7]]},"reference":[{"key":"BFgt20136_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.1088547","volume":"302","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415\u2013419.","journal-title":"Science"},{"key":"BFgt20136_CR2","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1172\/JCI35798","volume":"118","author":"SJ Howe","year":"2008","unstructured":"Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, Kempski H et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 2008; 118: 3143\u20133150.","journal-title":"J Clin Invest"},{"key":"BFgt20136_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nm1393","volume":"12","author":"MG Ott","year":"2006","unstructured":"Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006; 12: 401\u2013409.","journal-title":"Nat Med"},{"key":"BFgt20136_CR4","first-page":"10","volume":"8","author":"D Krause","year":"2011","unstructured":"Krause D . Gene therapy for Wiskott\u2013Aldrich syndrome: benefits and risks. The Hematologist 2011; 8: 10.","journal-title":"The Hematologist"},{"key":"BFgt20136_CR5","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1182\/blood-2005-08-024976","volume":"108","author":"U Modlich","year":"2006","unstructured":"Modlich U, Bohne J, Schmidt M, von Kalle C, Knoss S, Schambach A et al. Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood 2006; 108: 2545\u20132553.","journal-title":"Blood"},{"key":"BFgt20136_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/nbt1216","volume":"24","author":"E Montini","year":"2006","unstructured":"Montini E, Cesana D, Schmidt M, Sanvito F, Ponzoni M, Bartholomae C et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotech 2006; 24: 687\u2013696.","journal-title":"Nat Biotech"},{"key":"BFgt20136_CR7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/mt.2008.5","volume":"16","author":"D Zychlinski","year":"2008","unstructured":"Zychlinski D, Schambach A, Modlich U, Maetzig T, Meyer J, Grassman E et al. Physiological promoters reduce the genotoxic risk of integrating gene vectors. Mol Ther 2008; 16: 718\u2013725.","journal-title":"Mol Ther"},{"key":"BFgt20136_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/sj.mt.6300394","volume":"16","author":"PW Hargrove","year":"2008","unstructured":"Hargrove PW, Kepes S, Hanawa H, Obenauer JC, Pei D, Cheng C et al. Globin lentiviral vector insertions can perturb the expression of endogenous genes in [beta]-thalassemic hematopoietic cells. Mol Ther 2008; 16: 525\u2013533.","journal-title":"Mol Ther"},{"key":"BFgt20136_CR9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/stem.322","volume":"28","author":"T Winkler","year":"2010","unstructured":"Winkler T, Cantilena A, M\u00e9tais J-Y, Xu X, Nguyen A-D, Borate B et al. No evidence for clonal selection due to lentiviral integration sites in human induced pluripotent stem cells. Stem Cells 2010; 28: 687\u2013694.","journal-title":"Stem Cells"},{"key":"BFgt20136_CR10","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/mt.2011.20","volume":"19","author":"K Ronen","year":"2011","unstructured":"Ronen K, Negre O, Roth S, Colomb C, Malani N, Denaro M et al. Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat [beta]-thalassemia. Mol Ther 2011; 19: 1273\u20131286.","journal-title":"Mol Ther"},{"key":"BFgt20136_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/emmm.201000108","volume":"3","author":"L Biasco","year":"2011","unstructured":"Biasco L, Ambrosi A, Pellin D, Bartholomae C, Brigida I, Roncarolo MG et al. Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell. EMBO Mol Med 2011; 3: 89\u2013101.","journal-title":"EMBO Mol Med"},{"key":"BFgt20136_CR12","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/mt.2009.179","volume":"17","author":"U Modlich","year":"2009","unstructured":"Modlich U, Navarro S, Zychlinski D, Maetzig T, Knoess S, Brugman MH et al. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther 2009; 17: 1919\u20131928.","journal-title":"Mol Ther"},{"key":"BFgt20136_CR13","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature09328","volume":"467","author":"M Cavazzana-Calvo","year":"2010","unstructured":"Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F et al. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature 2010; 467: 318\u2013322.","journal-title":"Nature"},{"key":"BFgt20136_CR14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/mt.2009.51","volume":"17","author":"G Maruggi","year":"2009","unstructured":"Maruggi G, Porcellini S, Facchini G, Perna SK, Cattoglio C, Sartori D et al. Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design. Mol Ther 2009; 17: 851\u2013856.","journal-title":"Mol Ther"},{"key":"BFgt20136_CR15","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1038\/mt.2010.231","volume":"18","author":"NM Kane","year":"2010","unstructured":"Kane NM, Nowrouzi A, Mukherjee S, Blundell MP, Greig JA, Lee WK et al. Lentivirus-mediated reprogramming of somatic cells in the absence of transgenic transcription factors. Mol Ther 2010; 18: 2139\u20132145.","journal-title":"Mol Ther"},{"key":"BFgt20136_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1006\/mthe.2002.0672","volume":"6","author":"G Trobridge","year":"2002","unstructured":"Trobridge G, Josephson N, Vassilopoulos G, Mac J, Russell DW . Improved foamy virus vectors with minimal viral sequences. Mol Ther 2002; 6: 321\u2013328.","journal-title":"Mol Ther"},{"key":"BFgt20136_CR17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1128\/jvi.70.1.217-222.1996","volume":"70","author":"DW Russell","year":"1996","unstructured":"Russell DW, Miller AD . Foamy virus vectors. J Virol 1996; 70: 217\u2013222.","journal-title":"J Virol"},{"key":"BFgt20136_CR18","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1128\/jvi.71.10.7305-7311.1997","volume":"71","author":"A Moebes","year":"1997","unstructured":"Moebes A, Enssle J, Bieniasz PD, Heinkelein M, Lindemann D, Bock M et al. Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol 1997; 71: 7305\u20137311.","journal-title":"J Virol"},{"key":"BFgt20136_CR19","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1128\/JVI.73.2.1565-1572.1999","volume":"73","author":"SF Yu","year":"1999","unstructured":"Yu SF, Sullivan MD, Linial ML . Evidence that the human foamy virus genome is DNA. J Virol 1999; 73: 1565\u20131572.","journal-title":"J Virol"},{"key":"BFgt20136_CR20","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1073\/pnas.0510046103","volume":"103","author":"GD Trobridge","year":"2006","unstructured":"Trobridge GD, Miller DG, Jacobs MA, Allen JM, Kiem HP, Kaul R et al. Foamy virus vector integration sites in normal human cells. Proc Natl Acad Sci USA 2006; 103: 1498\u20131503.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt20136_CR21","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/sj.mt.6300398","volume":"16","author":"PC Hendrie","year":"2008","unstructured":"Hendrie PC, Huo Y, Stolitenko RB, Russell DW . A rapid and quantitative assay for measuring neighboring gene activation by vector proviruses. Mol Ther 2008; 16: 534\u2013540.","journal-title":"Mol Ther"},{"key":"BFgt20136_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nm1695","volume":"14","author":"TR Bauer","year":"2008","unstructured":"Bauer TR, Allen JM, Hai M, Tuschong LM, Khan IF, Olson EM et al. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors. Nat Med 2008; 14: 93\u201397.","journal-title":"Nat Med"},{"key":"BFgt20136_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/hum.2010.072","volume":"22","author":"K Ohmine","year":"2011","unstructured":"Ohmine K, Li Y, Bauer TR, Hickstein DD, Russell DW . Tracking of specific integrant clones in dogs treated with foamy virus vectors. Hum Gene Ther 2011; 22: 217\u2013224.","journal-title":"Hum Gene Ther"},{"key":"BFgt20136_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/mt.2011.209","volume":"20","author":"DR Deyle","year":"2012","unstructured":"Deyle DR, Khan IF, Ren G, Wang PR, Kho J, Schwarze U et al. Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs. Mol Ther 2012; 20: 204\u2013213.","journal-title":"Mol Ther"},{"key":"BFgt20136_CR25","doi-asserted-by":"publisher","first-page":"4670","DOI":"10.1128\/MCB.9.11.4670","volume":"9","author":"T Tsukiyama","year":"1989","unstructured":"Tsukiyama T, Niwa O, Yokoro K . Mechanism of suppression of the long terminal repeat of Moloney leukemia virus in mouse embryonal carcinoma cells. Mol Cell Biol 1989; 9: 4670\u20134676.","journal-title":"Mol Cell Biol"},{"key":"BFgt20136_CR26","doi-asserted-by":"publisher","first-page":"20641","DOI":"10.1073\/pnas.0809680106","volume":"105","author":"NS Hwang","year":"2008","unstructured":"Hwang NS, Varghese S, Lee HJ, Zhang Z, Ye Z, Bae J et al. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci USA 2008; 105: 20641\u201320646.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt20136_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature05610","volume":"446","author":"C Greenman","year":"2007","unstructured":"Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G et al. Patterns of somatic mutation in human cancer genomes. Nature 2007; 446: 153\u2013158.","journal-title":"Nature"},{"key":"BFgt20136_CR28","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/ng.438","volume":"41","author":"TD Prickett","year":"2009","unstructured":"Prickett TD, Agrawal NS, Wei X, Yates KE, Lin JC, Wunderlich JR et al. Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4. Nat Genet 2009; 41: 1127\u20131132.","journal-title":"Nat Genet"},{"key":"BFgt20136_CR29","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature07423","volume":"455","author":"L Ding","year":"2008","unstructured":"Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008; 455: 1069\u20131075.","journal-title":"Nature"},{"key":"BFgt20136_CR30","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/ijc.21507","volume":"118","author":"YH Soung","year":"2006","unstructured":"Soung YH, Lee JW, Kim SY, Wang YP, Jo KH, Moon SW et al. Somatic mutations of the ERBB4 kinase domain in human cancers. Int J Cancer 2006; 118: 1426\u20131429.","journal-title":"Int J Cancer"},{"key":"BFgt20136_CR31","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1073\/pnas.0507496103","volume":"103","author":"A Recchia","year":"2006","unstructured":"Recchia A, Bonini C, Magnani Z, Urbinati F, Sartori D, Muraro S et al. Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells. Proc Natl Acad Sci USA 2006; 103: 1457\u20131462.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt20136_CR32","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/mt.2009.7","volume":"17","author":"CL Li","year":"2009","unstructured":"Li CL, Xiong D, Stamatoyannopoulos G, Emery DW . Genomic and functional assays demonstrate reduced gammaretroviral vector genotoxicity associated with use of the cHS4 chromatin insulator. Mol Ther 2009; 17: 716\u2013724.","journal-title":"Mol Ther"},{"key":"BFgt20136_CR33","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1038\/mt.2009.183","volume":"17","author":"PI Arumugam","year":"2009","unstructured":"Arumugam PI, Higashimoto T, Urbinati F, Modlich U, Nestheide S, Xia P et al. Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control region. Mol Ther 2009; 17: 1929\u20131937.","journal-title":"Mol Ther"},{"key":"BFgt20136_CR34","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/gt.2011.12","volume":"18","author":"D Almarza","year":"2011","unstructured":"Almarza D, Bussadori G, Navarro M, Mavilio F, Larcher F, Murillas R . Risk assessment in skin gene therapy: viral-cellular fusion transcripts generated by proviral transcriptional read-through in keratinocytes transduced with self-inactivating lentiviral vectors. Gene Ther 2011; 18: 674\u2013681.","journal-title":"Gene Ther"},{"key":"BFgt20136_CR35","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1182\/blood-2005-03-1113","volume":"106","author":"Y Du","year":"2005","unstructured":"Du Y, Jenkins NA, Copeland NG . Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 2005; 106: 3932\u20133939.","journal-title":"Blood"},{"key":"BFgt20136_CR36","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1172\/JCI61852","volume":"122","author":"A Moiani","year":"2012","unstructured":"Moiani A, Paleari Y, Sartori D, Mezzadra R, Miccio A, Cattoglio C et al. Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts. J Clin Invest 2012; 122: 1653\u20131666.","journal-title":"J Clin Invest"},{"key":"BFgt20136_CR37","doi-asserted-by":"publisher","first-page":"9088","DOI":"10.1128\/JVI.00485-12","volume":"86","author":"S Knight","year":"2012","unstructured":"Knight S, Zhang F, Mueller-Kuller U, Bokhoven M, Gupta A, Broughton T et al. Safer, silencing-resistant lentiviral vectors: optimization of the ubiquitous chromatin-opening element through elimination of aberrant splicing. J Virol 2012; 86: 9088\u20139095.","journal-title":"J Virol"},{"key":"BFgt20136_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/sj.mt.6300339","volume":"16","author":"JR Chamberlain","year":"2008","unstructured":"Chamberlain JR, Deyle DR, Schwarze U, Wang P, Hirata RK, Li Y et al. Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta. Mol Ther 2008; 16: 187\u2013193.","journal-title":"Mol Ther"},{"key":"BFgt20136_CR39","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1093\/nar\/25.18.3745","volume":"25","author":"KL Tucker","year":"1997","unstructured":"Tucker KL, Wang Y, Dausman J, Jaenisch R . A transgenic mouse strain expressing four drug-selectable marker genes. Nucleic Acids Res 1997; 25: 3745\u20133746.","journal-title":"Nucleic Acids Res"},{"key":"BFgt20136_CR40","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1126\/science.1172482","volume":"324","author":"J Yu","year":"2009","unstructured":"Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324: 797\u2013801.","journal-title":"Science"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt20136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt20136","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt20136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T11:34:10Z","timestamp":1648553650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt20136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,7]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["BFgt20136"],"URL":"https:\/\/doi.org\/10.1038\/gt.2013.6","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,7]]},"assertion":[{"value":"28 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}